Constellation Acq CRP WTS (CSTWF) Financials
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 17, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CSTWF SEC filings page.
This page shows Constellation Acq CRP WTS (CSTWF) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
The reported balance sheet has shrunk dramatically while liabilities remain large, and the organization still consumes cash from operations.
Liabilities represented2681.1% of assets in FY2025 versus170.5% in FY2024, because assets fell to$901K while obligations remained$24.2M . This is more than a smaller balance sheet: the remaining asset base is increasingly dominated by claims against it.
Operating losses narrowed from
Near-term liquidity is exceptionally constrained: a current ratio of 0.0042 pairs
Financial Health Signals
We do not publish a peer-relative financial health score for Constellation Acq CRP WTS, because the score only covers companies whose filings and listing give us what it needs to compare them with their peers. The signals and metrics below are current.
Constellation Acq CRP WTS passes 1 of 5 computable financial strength tests (4 of the nine could not be computed from available data). 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution).
Constellation Acq CRP WTS reported a net loss of $3.2M while operations used $470K of cash. With neither figure positive, the ratio between the two carries no quality signal.
Key Financial Metrics
Earnings & Revenue
Constellation Acq CRP WTS reported a net loss of $3.3M in Q2 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Not reported for Q2 2026.
Not reported for Q2 2026.
Not reported for Q2 2026.
Cash & Balance Sheet
Constellation Acq CRP WTS held $18K in cash as of Q2 2026; no long-term debt figure is on record for that period.
Not reported for Q2 2026.
Not reported for Q2 2026.
Margins & Returns
None of these metrics is reported for Q2 2026.
Capital Allocation
Constellation Acq CRP WTS repurchased no shares in Q2 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. Against the prior quarter it is down 100.0%.
Not reported for Q2 2026.
Not reported for Q2 2026.
CSTWF Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| SG&A Expenses | $1.1M+325.3% | $2.0M+371.6% | N/A | $248K+1.4% | $265K+17.4% | $415K-47.4% | $313K-73.9% | $245K-66.5% |
| Operating Income | -$1.1Mn/m | -$2.0Mn/m | -$141Kn/m | -$248Kn/m | -$265Kn/m | -$415Kn/m | -$313Kn/m | -$245Kn/m |
| Net Income | -$3.3Mn/m | -$687Kn/m | -$1.2M-38245.4% | -$1.3M-3631.2% | -$221K-207.8% | -$447Kn/m | $3Kn/m | $38K-87.7% |
Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, EBITDA, Interest Expense, Income Tax, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).
CSTWF Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $691K-19.3% | $682K-19.5% | $901K-96.8% | $873K-96.9% | $856K-96.9% | $847K-96.8% | $28.2M-43.5% | $27.8M-43.2% |
| Current Assets | $30K-24.8% | $40K-24.8% | $42K-32.2% | $35K-73.9% | $40K-19.0% | $54K-58.9% | $62K+66.6% | $135K-14.8% |
| Cash & Equivalents | $18K+265.9% | $5K-43.9% | $5K-6.4% | $9K+55.5% | $5K-31.2% | $9K+137.0% | $5K+49.8% | $6K+356.6% |
| Short-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Long-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Total Liabilities | $21.4M-0.4% | $24.6M+16.0% | $24.2M-49.7% | $22.9M-51.6% | $21.5M-53.5% | $21.3M-53.4% | $48.0M-28.9% | $47.2M-27.5% |
| Current Liabilities | $13.0M+37.1% | $11.9M+28.8% | $9.9M+12.6% | $9.8M+16.1% | $9.5M+20.1% | $9.2M+21.5% | $8.8M+34.4% | $8.4M+67.3% |
| Non-Current Liabilities | $8.4M-30.0% | $12.8M+6.2% | $14.2M-63.7% | $13.1M-66.2% | $12.0M-68.7% | $12.0M-68.4% | $39.2M-35.7% | $38.8M-35.4% |
| Total Equity | -$20.7Mn/m | -$24.0Mn/m | -$23.3Mn/m | -$22.0Mn/m | -$20.6Mn/m | -$20.4Mn/m | -$19.9Mn/m | -$19.4Mn/m |
| Retained Earnings | -$20.7Mn/m | -$24.0Mn/m | -$23.3Mn/m | -$22.0Mn/m | -$20.6Mn/m | -$20.4Mn/m | -$19.9Mn/m | -$19.4Mn/m |
Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill, Long-Term Debt.
CSTWF Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$247Kn/m | -$140Kn/m | -$94Kn/m | -$86Kn/m | -$109Kn/m | -$181Kn/m | -$75Kn/m | -$226Kn/m |
| Investing Cash Flow | -$15Kn/m | $223K | -$15Kn/m | -$15Kn/m | -$15Kn/m | N/A | -$165Kn/m | -$165Kn/m |
| Financing Cash Flow | $275K+129.2% | -$83K | $105K-56.3% | $105K-73.1% | $120K-54.7% | N/A | $240K-69.4% | $390K-18.9% |
| Share Buybacks | $0n/m | $238K | $0n/m | $0n/m | $0n/m | N/A | $0n/m | $0n/m |
Not reported in any period shown, so not listed: Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Dividends Paid.
CSTWF Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Debt-to-Equity, Liabilities-to-Equity, Asset Turnover, FCF Margin.
Note: Shareholder equity is negative (-$23.3M), which causes the debt-to-equity, liabilities-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.00), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Where Constellation Acq CRP WTS Ranks
Frequently Asked Questions
No, Constellation Acq CRP WTS (CSTWF) reported a net loss of $6.5M over the trailing 12 months to June 30, 2026. In fiscal year 2025 it reported a net loss of $3.2M.
Constellation Acq CRP WTS (CSTWF) recorded an outflow of $470K in operating cash flow during fiscal year 2025, representing cash used by core business activities.
Constellation Acq CRP WTS (CSTWF) had $901K in total assets as of fiscal year 2025, including both current and long-term assets.
Constellation Acq CRP WTS (CSTWF) had a current ratio of 0.00 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
Constellation Acq CRP WTS (CSTWF) had a return on assets of -359.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
Constellation Acq CRP WTS (CSTWF) has negative shareholder equity of -$23.3M as of fiscal year 2025, so no debt-to-equity or liabilities-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
Constellation Acq CRP WTS (CSTWF) has a Piotroski F-Score of 1 out of 5 computable signals; 4 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Constellation Acq CRP WTS (CSTWF) reported a net loss of $3.2M while operations used $470K of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.